Skip to main content
. 2021 Nov 5;7(4):e25648. doi: 10.2196/25648

Table 5.

Severity of delayed nausea between cycles of chemotherapy.

Severity Cycle 2, n (%) Cycle 3, n (%) Cycle 4, n (%) End of study, n (%) P value

FRa group (n=9) Control group (n=16) FR group (n=9) Control group (n=17) FR group (n=7) Control group (n=14) FR group (n=7) Control group (n=12)
Very low to moderate 7 (78) 11 (69) 8 (89) 12 (71) 6 (86) 11 (79) 6 (86) 8 (67) .39
Severe to unbearable 2 (22) 5 (31) 1 (11) 5 (29) 1 (14) 3 (21) 1 (14) 4 (33) b

aFR: foot reflexology.

bThe P value for the entire group comparison is reported only in the top row.